Literature DB >> 20658246

Afferent facilitation of corticomotor responses is increased by IgGs of patients with NMDA-receptor antibodies.

Mario Manto1, Josep Dalmau, Adrien Didelot, Véronique Rogemond, Jérôme Honnorat.   

Abstract

A severe subacute encephalitis associated with auto-antibodies to the NMDA receptor (NMDA-R) has been reported in humans. These antibodies are directed to NR1/NR2 heteromers of the NMDA receptor. We studied the effects of patients' cerebrospinal fluid (CSF) injected in rFr2 (the prefrontal area) on the afferent facilitation in a conditioning paradigm for corticomotor responses. The afferent facilitation was assessed in forelimbs and hindlimbs of rats, before and after application of trains of high-frequency stimulation (HFS) which are known to modulate the excitability of M1. Before HFS, patients' CSF did not modify afferent facilitation. After HFS, the amplitudes of corticomotor responses before conditioning were significantly larger in forelimbs and hindlimbs. There was an increase of the afferent facilitation in forelimbs. The same effect was observed after injection of purified IgGs from patients' sera. Our results highlight that IgGs of patients with NMDA-R antibodies induce a state of corticomotor hyperexcitability following application of HFS over the prefrontal area.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20658246      PMCID: PMC3086668          DOI: 10.1007/s00415-010-5674-5

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  21 in total

1.  Distinct changes in cortical and spinal excitability following high-frequency repetitive TMS to the human motor cortex.

Authors:  Angelo Quartarone; Sergio Bagnato; Vincenzo Rizzo; Francesca Morgante; Antonio Sant'angelo; Fortunato Battaglia; Corrado Messina; Hartwig Roman Siebner; Paolo Girlanda
Journal:  Exp Brain Res       Date:  2004-12-02       Impact factor: 1.972

2.  NMDA/AMPA ratio impacts state transitions and entrainment to oscillations in a computational model of the nucleus accumbens medium spiny projection neuron.

Authors:  John A Wolf; Jason T Moyer; Maciej T Lazarewicz; Diego Contreras; Marianne Benoit-Marand; Patricio O'Donnell; Leif H Finkel
Journal:  J Neurosci       Date:  2005-10-05       Impact factor: 6.167

3.  Hemicerebellectomy blocks the enhancement of cortical motor output associated with repetitive somatosensory stimulation in the rat.

Authors:  Nordeyn Oulad Ben Taib; Oulad Ben Taib Nordeyn; Mario Manto; Manto Mario; Massimo Pandolfo; Pandolfo Massimo; Jacques Brotchi; Brotchi Jacques
Journal:  J Physiol       Date:  2005-06-09       Impact factor: 5.182

4.  Hemicerebellectomy impairs the modulation of cutaneomuscular reflexes by the motor cortex following repetitive somatosensory stimulation.

Authors:  Nordeyn Oulad Ben Taib; Mario Manto
Journal:  Brain Res       Date:  2006-04-25       Impact factor: 3.252

5.  Differential thalamic connectivity of rostral and caudal parts of cortical area Fr2 in rats.

Authors:  R R Hicks; M F Huerta
Journal:  Brain Res       Date:  1991-12-24       Impact factor: 3.252

6.  Autoimmune limbic encephalitis in 39 patients: immunophenotypes and outcomes.

Authors:  L Bataller; K A Kleopa; G F Wu; J E Rossi; M R Rosenfeld; J Dalmau
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-09-15       Impact factor: 10.154

7.  Laser Doppler flowmetry is valid for measurement of cerebral blood flow autoregulation lower limit in rats.

Authors:  Jan Tonnesen; Anders Pryds; Erik H Larsen; Olaf B Paulson; John Hauerberg; Gitte M Knudsen
Journal:  Exp Physiol       Date:  2005-01-14       Impact factor: 2.969

8.  Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.

Authors:  Josep Dalmau; Erdem Tüzün; Hai-yan Wu; Jaime Masjuan; Jeffrey E Rossi; Alfredo Voloschin; Joachim M Baehring; Haruo Shimazaki; Reiji Koide; Dale King; Warren Mason; Lauren H Sansing; Marc A Dichter; Myrna R Rosenfeld; David R Lynch
Journal:  Ann Neurol       Date:  2007-01       Impact factor: 10.422

9.  Rapid and precise method to locate microdialysis probe implantation in the rodent brain.

Authors:  L Bert; D Favale; G Jego; P Greve; J-P Guilloux; B P Guiard; A M Gardier; M F Suaud-Chagny; P Lestage
Journal:  J Neurosci Methods       Date:  2004-12-30       Impact factor: 2.390

10.  Evidence for antibody-mediated pathogenesis in anti-NMDAR encephalitis associated with ovarian teratoma.

Authors:  Erdem Tüzün; Lei Zhou; Joachim M Baehring; Serguei Bannykh; Myrna R Rosenfeld; Josep Dalmau
Journal:  Acta Neuropathol       Date:  2009-12       Impact factor: 17.088

View more
  16 in total

Review 1.  Infections, inflammation and epilepsy.

Authors:  Annamaria Vezzani; Robert S Fujinami; H Steve White; Pierre-Marie Preux; Ingmar Blümcke; Josemir W Sander; Wolfgang Löscher
Journal:  Acta Neuropathol       Date:  2015-09-30       Impact factor: 17.088

2.  Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity.

Authors:  C Hammer; B Stepniak; A Schneider; S Papiol; M Tantra; M Begemann; A-L Sirén; L A Pardo; S Sperling; S Mohd Jofrry; A Gurvich; N Jensen; K Ostmeier; F Lühder; C Probst; H Martens; M Gillis; G Saher; F Assogna; G Spalletta; W Stöcker; T F Schulz; K-A Nave; H Ehrenreich
Journal:  Mol Psychiatry       Date:  2013-09-03       Impact factor: 15.992

Review 3.  Neuronal central nervous system syndromes probably mediated by autoantibodies.

Authors:  Aude Chefdeville; Jérôme Honnorat; Christiane S Hampe; Virginie Desestret
Journal:  Eur J Neurosci       Date:  2016-03-28       Impact factor: 3.386

4.  A mouse model of seizures in anti-N-methyl-d-aspartate receptor encephalitis.

Authors:  Olga Taraschenko; Howard S Fox; Sean J Pittock; Anastasia Zekeridou; Maftuna Gafurova; Ember Eldridge; Jinxu Liu; Shashank M Dravid; Raymond Dingledine
Journal:  Epilepsia       Date:  2019-02-11       Impact factor: 5.864

5.  Effects of Anti-NMDA Antibodies on Functional Recovery and Synaptic Rearrangement Following Hemicerebellectomy.

Authors:  Daniela Laricchiuta; Virve Cavallucci; Debora Cutuli; Paola De Bartolo; Paola Caporali; Francesca Foti; Carsten Finke; Marcello D'Amelio; Mario Manto; Laura Petrosini
Journal:  Neuromolecular Med       Date:  2016-03-30       Impact factor: 3.843

Review 6.  Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis.

Authors:  Josep Dalmau; Eric Lancaster; Eugenia Martinez-Hernandez; Myrna R Rosenfeld; Rita Balice-Gordon
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

Review 7.  Neuronal autoantigens--pathogenesis, associated disorders and antibody testing.

Authors:  Eric Lancaster; Josep Dalmau
Journal:  Nat Rev Neurol       Date:  2012-06-19       Impact factor: 42.937

Review 8.  Glutamate receptor antibodies in neurological diseases: anti-AMPA-GluR3 antibodies, anti-NMDA-NR1 antibodies, anti-NMDA-NR2A/B antibodies, anti-mGluR1 antibodies or anti-mGluR5 antibodies are present in subpopulations of patients with either: epilepsy, encephalitis, cerebellar ataxia, systemic lupus erythematosus (SLE) and neuropsychiatric SLE, Sjogren's syndrome, schizophrenia, mania or stroke. These autoimmune anti-glutamate receptor antibodies can bind neurons in few brain regions, activate glutamate receptors, decrease glutamate receptor's expression, impair glutamate-induced signaling and function, activate blood brain barrier endothelial cells, kill neurons, damage the brain, induce behavioral/psychiatric/cognitive abnormalities and ataxia in animal models, and can be removed or silenced in some patients by immunotherapy.

Authors:  Mia Levite
Journal:  J Neural Transm (Vienna)       Date:  2014-08-01       Impact factor: 3.575

Review 9.  Autoimmune synaptopathies.

Authors:  Sarah J Crisp; Dimitri M Kullmann; Angela Vincent
Journal:  Nat Rev Neurosci       Date:  2016-02       Impact factor: 34.870

Review 10.  Paraneoplastic neurological syndrome: an evolving story.

Authors:  Jiraporn Jitprapaikulsan; Pritikanta Paul; Smathorn Thakolwiboon; Shivam Om Mittal; Sean J Pittock; Divyanshu Dubey
Journal:  Neurooncol Pract       Date:  2021-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.